IFNG and inflammatory bowel disease: As discussed previously, current efforts at developing treatments for various forms of IBD, particularly ulcerative colitis, have focused extensively on devising costly new biologic agents, many of which act by specifically targeting cytokines including TNFα and IFNγ [48].